#oncology

Collection of oncology news, found 184 news.

CMC Biologics Announces Agreement With Daiichi Sankyo Company to Develop and Manufacture Antibodies

-             CMC Biologics today announced the execution of an ...

Abbott to Separate into Two Leading Companies in Diversified Medical Products

-     Two publicly traded companies will offer shareholder distinct opportunities given unique ...

Roche and Diagnostica Stago Terminate Partnership

-         Roche Professional Diagnostics and Diagnostica Stago announced today that the ...

Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metast

-      March 2011 Data Confirm Strong Treatment Effect of ...

New ESC Guidelines Recommend Efient(R) (Prasugrel) as First-line Antiplatelet Therapy for Patients w

-    In new guidelines from the European Society of Cardiology (ESC), prasugrel - a once daily oral ...

New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST

-        - This release is not intended for US ...

BRILINTA Mortality Benefit in Blinded Review of Post-CABG PLATO Patients Driven by Fewer Cardiac, Bl

-        This Release is Not Intended for US Media        ...

CRESTOR Delivers Superior Efficacy in Achievement of Low LDL-C Targets in New VOYAGER Analysis

-        - This release is not intended for US and Canadian media    ...

Effient(R) (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopido

-Analysis evaluated efficacy and safety among three patient sub-groups        A new ...

23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials

-Initial Results are Encouraging, Spurring Hope for a Treatment Option with a Lower Rate of ...

Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery

-       Jubilant Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and ...

Jubilant and Endo Pharmaceuticals Announce Late Stage Discovery Milestone in Oncology Program

-    Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd., and Endo ...

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

-        - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...

Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Result

- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...

Cancer vaccine creator Ian Frazer visits Indonesia

Professor Ian Frazer, creator of the HPV vaccine against cervical cancer will visit Indonesia from 25 to 28 April ...